...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >FORMULATION AND EVALUATION OF VINPOCETINE ORODISPERSIBLE TABLETS: IN-VITRO CHARACTERIZATION AND IN-VIVO PHARMACOKINETIC STUDY
【24h】

FORMULATION AND EVALUATION OF VINPOCETINE ORODISPERSIBLE TABLETS: IN-VITRO CHARACTERIZATION AND IN-VIVO PHARMACOKINETIC STUDY

机译:VINPOCETINE ORODISPERSIBLE平板电脑的配方和评价:体外表征和体内药代动力学研究

获取原文
           

摘要

Objective: This research article aims to formulate and evaluate orodispersible tablets (ODTs) for Vinpocetine, a nootropic drug used for improving brain functions and cerebral blood flow. This will provide a convenient way for taking medication for dysphagia patients and therefore improve compliance. Methods: Vinpocetine ODTs were prepared by using superdisintegrants. A full mixed 3 1 ×4 1 factorial design was applied to evaluate the effect of two independent variables, namely superdisintegrant type (crospovidone, croscarmellose sodium and sodium starch glycolate) and superdisintegrant concentration (2.5, 5, 7.5, and 10%) on four responses namely friability, disintegration time, wetting time and dissolution percent after 5 min. Compatibility study was carried out using differential scanning calorimetry. Various physico-chemical properties were measured, and in-vivo pharmaco-kinetic study for a selected formula was performed against a conventional tablet market product. Results: Results showed that formulae ingredients were compatible. Crospovidone showed the shortest disintegration time and wetting time. Friability was less than 1%in all formulae, and dissolution percent after 5 min was greater than 80% in all formulae. Statistical evaluation of the results showed that tablets prepared by crospovidone showed the highest desirability value. The in-vivo study showed higher C max and AUC of ODTs over conventional tablets. Conclusion: It can be concluded that vinpocetine ODTs can be successfully prepared using superdisintegrants, and the selected ODT formulation showed improved bioavailability compared to conventional tablet market product.
机译:目的:本研究制品旨在为vinpocetine进行制定和评估orodispersible片剂(Otods),一种用于改善脑功能和脑血流的垂直药。这将为服用吞咽患者服用药物,从而提供改善合规性。方法:通过使用超级分子制备vinPocetine ODTS。应用完整的3 1×4 1因子设计来评估两个独立变量,即超级融合型(Crospovidone,Croscarmellose钠和钠淀粉糖酸钠)和超级聚合物浓度(2.5,5,7.5和10%)的效果在5分钟后反应即脆性,崩解时间,润湿时间和溶解百分比。使用差示扫描量热法进行兼容性研究。测量各种物理化学性质,并针对常规的片剂市场产品进行用于所选式的体内药房研究。结果:结果表明,公式成分均相容。 Crospovidone显示最短的崩解时间和润湿时间。在所有配方中,脆性小于1%,并且在所有配方中,5分钟后的溶解百分比大于80%。结果表明,通过Crospovidone制备的片剂表现出最高的期望值。体内研究表现出常规片剂的含量高的C max和Auc。结论:可以得出结论,与传统的平板电脑市场产品相比,可以成功地制备vinPocetine ODTS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号